The goal of the colloquium is to showcase the synergistic interaction between chemistry, biology, pharmacology, and bioinformatics in the process of drug development. Our aim is to promote the professional dialogue between students and experts from different disciplines interested in the processes of drug discovery and development. This conference provides a platform for undergraduate, graduate students, and post-doctoral fellows to present their research. This conference will also include a professional development session, and provides great networking opportunities.
DDDC 2018 – Preliminary Schedule
*****Registration and abstract submission deadline EXTENDED to June 7, 2018
Call for Participation
The Conference Program Committee invites you to submit an abstract for either a poster or oral presentation. Abstracts are limited to 300 words in length.
For registration click here
Oral abstract deadline June 7, 2018
Poster abstract deadline June 7, 2018
Oral presentation acceptance June 13, 2018
Poster presentation acceptance June 13, 2018
We have sufficient space for all poster abstracts to be accepted.
Poster size limitation: 48″W x 36″H (122cm x 91cm)
For Venue and Hotel details, click here
Professor, Medicinal Chemistry, College of Pharmacy,
University of Florida.
Director, Division of Bioinformatics and Biostatistics,
National Center for Toxicological Research.
Simmons Chair in Cancer Research,
Professor and Chairman,
Dept. of Pharmaceutical Sciences, College of Pharmacy,
University of Arkansas for Medical Sciences.
Title: Understanding the NFkB Pathway in Cancer Cells: New Insights into Anticancer Drug Discovery.
Assistant Member Faculty,
Chemical Biology and Therapeutics,
St. Jude Children’s Research Hospital.
Title: Natural products for understanding and treating disease.